You have Guest access.
Log In
Posters
Book Chapter
Supportive Care
David Bowen
Hematologic Malignancies, 2006, Hematologic Malignancies: Myelodysplastic Syndromes, Pages 95-98
Cardioprotective Effect of Iron Chelators
Chaim Hershko, Gabriela Link and Abraham M Konijn
Advances in Experimental Medicine and Biology, 1, Volume 509, Iron Chelation Therapy, Pages 77-89
Results of Long Term Iron Chelation Treatment with Deferoxamine
Bernard A. Davis and John B. Porter
Advances in Experimental Medicine and Biology, 1, Volume 509, Iron Chelation Therapy, Pages 91-125
Long Term Deferiprone Chelation Therapy
Victor A Hoffbrand and Beatrix Wonke
Advances in Experimental Medicine and Biology, 1, Volume 509, Iron Chelation Therapy, Pages 127-139
Myelodysplastic Syndromes (MDS)
Lisa Pleyer, Daniel Neureiter, Victoria Faber and Richard Greil
2010, Chronic Myeloid Neoplasias and Clonal Overlap Syndromes, Pages 153-222
Protocol
Nanoparticle and Iron Chelators as a Potential Novel Alzheimer Therapy
Gang Liu, Ping Men, George Perry and Mark A. Smith
Methods in Molecular Biology™, 1, Volume 610, Free Radicals and Antioxidant Protocols, Part 2, Pages 123-144
Hereditary Hemochromatosis and Iron Overload
Claus Niederau
2010, Clinical Hepatology, Part IV, Part 8, Pages 1045-1070
Journal Article
Hepatic iron deposition in human disease and animal models
June W. Halliday and Jeffrey Searle
BioMetals, 1996, Volume 9, Number 2, Pages 205-209
Pathogenesis and Management of Iron Overload in MDS
Chaim Hershko
2011, The Myelodysplastic Syndromes, Pages 187-204
Iron overload and desferrioxamine chelation therapy in β-thalassemia intermedia
P. Cossu, C. Toccafondi, F. Vardeu, G. Sanna and F. Frau, et al.
European Journal of Pediatrics, 1981, Volume 137, Number 3, Pages 267-271
Frequently asked questions General info on journals and books Send us your feedback Impressum Contact us
© Springer, Part of Springer Science+Business Media Privacy, Disclaimer, Terms & Conditions, and Copyright Info